TRIM38 inhibits TNFα- and IL-1β-triggered NF-κB activation by mediating lysosome-dependent degradation of TAB2/3

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 4, 2014, Pages 1509-1514

  Hu, Ming Ming ^a   Yang, Qing ^a   Zhang, Jing ^a   Liu, Shi Meng ^a   Zhang, Yu ^a   Lin, Heng ^a   Huang, Zhe Fu ^b   Wang, Yan Yi ^b   Zhang, Xiao Dong ^a   Zhong, Bo ^a   Shu, Hong Bing ^a  

^a WUHAN UNIVERSITY   (China)

^b WUHAN INSTITUTE OF VIROLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TAB 2 3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; TRIPARTITE MOTIF PROTEIN 38; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG;

ARTICLE; CELL STRAIN HCT116; CELL STRAIN HEK293; CONTROLLED STUDY; ENDOSOME; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HELA CELL; HUMAN; HUMAN CELL; LYSOSOME; POLYMERASE CHAIN REACTION SYSTEM; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; BASE SEQUENCE; CARRIER PROTEINS; DNA PRIMERS; HUMANS; INTERLEUKIN-1BETA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LYSOSOMES; NF-KAPPA B; PROTEOLYSIS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84893393844     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1318227111     Document Type: Article

References (25)

1. Hayden MS, Ghosh S (2011) NF-κB in immunobiology. Cell Res 21(2):223-244.
2. Hayden MS, Ghosh S (2012) NF-κB, the first quarter-century: Remarkable progress and outstanding questions. Genes Dev 26(3):203-234.
3. Razani B, Cheng G (2010) NF-kappaB: Much learned, much to learn. Sci Signal 3(138): pe29.
4. Oeckinghaus A, Hayden MS, Ghosh S (2011) Crosstalk in NF-κB signaling pathways. Nat Immunol 12(8):695-708.
5. Verstrepen L, et al. (2008) TLR-4, IL-1R and TNF-R signaling to NF-kappaB: Variations on a common theme. Cell Mol Life Sci 65(19):2964-2978.
6. Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7(8):758-765.
7. Weber A, Wasiliew P, Kracht M (2010) Interleukin-1 (IL-1) pathway. Sci Signal 3(105): cm1.
8. Chen R, Li M, Zhang Y, Zhou Q, Shu HB (2012) The E3 ubiquitin ligase MARCH8 negatively regulates IL-1β-induced NF-κB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation. Proc Natl Acad Sci USA 109(35):14128-14133.
9. Mahoney DJ, et al. (2008) Both cIAP1 and cIAP2 regulate TNFalpha-mediated NFkappaB activation. Proc Natl Acad Sci USA 105(33):11778-11783.
10. Tian Y, et al. (2007) RBCK1 negatively regulates tumor necrosis factor- and interleukin- 1-triggered NF-kappaB activation by targeting TAB2/3 for degradation. J Biol Chem 282(23):16776-16782.
11. Gong J, Shen XH, Qiu H, Chen C, Yang RG (2011) Rhesus monkey TRIM5α represses HIV-1 LTR promoter activity by negatively regulating TAK1/TAB1/TAB2/TAB3-complex- mediated NF-κB activation. Arch Virol 156(11):1997-2006.
12. Heyninck K, Beyaert R (1999) The cytokine-inducible zinc finger protein A20 inhibits IL-1-induced NF-kappaB activation at the level of TRAF6. FEBS Lett 442(2-3):147-150.
13. He X, et al. (2013) USP2a negatively regulates IL-1β- and virus-induced NF-κB activation by deubiquitinating TRAF6. J Mol Cell Biol 5(1):39-47.
14. Xiao N, et al. (2012) Ubiquitin-specific protease 4 (USP4) targets TRAF2 and TRAF6 for deubiquitination and inhibits TNFα-induced cancer cell migration. Biochem J 441(3): 979-986.
15. Yasunaga J, Lin FC, Lu X, Jeang KT (2011) Ubiquitin-specific peptidase 20 targets TRAF6 and human T cell leukemia virus type 1 tax to negatively regulate NF-kappaB signaling. J Virol 85(13):6212-6219.
16. Trompouki E, et al. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424(6950):793-796.
17. Saito K, et al. (2004) The CAP-Gly domain of CYLD associates with the proline-rich sequence in NEMO/IKKgamma. Structure 12(9):1719-1728.
18. Fan YH, et al. (2011) USP4 targets TAK1 to downregulate TNFα-induced NF-κB activation. Cell Death Differ 18(10):1547-1560.
19. Wang L, Du F, Wang X (2008) TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133(4):693-703.
20. Zheng H, et al. (2013) The dual-specificity phosphatase DUSP14 negatively regulates tumor necrosis factor- and interleukin-1-induced nuclear factor-κB activation by dephosphorylating the protein kinase TAK1. J Biol Chem 288(2):819-825.
21. Uchil PD, et al. (2013) TRIM protein-mediated regulation of inflammatory and innate immune signaling and its association with antiretroviral activity. J Virol 87(1):257-272.
22. Zhao W, et al. (2012) Tripartite motif-containing protein 38 negatively regulates TLR3/4- and RIG-I-mediated IFN-β production and antiviral response by targeting NAP1. J Immunol 188(11):5311-5318.
23. Zhao W, Wang L, Zhang M, Yuan C, Gao C (2012) E3 ubiquitin ligase tripartite motif 38 negatively regulates TLR-mediated immune responses by proteasomal degradation of TNF receptor-associated factor 6 in macrophages. J Immunol 188(6):2567-2574.
24. Xue Q, et al. (2012) TRIM38 negatively regulates TLR3-mediated IFN-β signaling by targeting TRIF for degradation. PLoS ONE 7(10):e46825.
25. Jiang Z, Ninomiya-Tsuji J, Qian Y, Matsumoto K, Li X (2002) Interleukin-1 (IL-1) receptor- associated kinase-dependent IL-1-induced signaling complexes phosphorylate TAK1 and TAB2 at the plasma membrane and activate TAK1 in the cytosol. Mol Cell Biol 22(20):7158-7167.